Chris is the Director of Finance for Gate Neurosciences. He brings over 10 years of experience developing and leading accounting and finance functions within advisory and healthcare organizations.

Chris spent his early career in Public Accounting with BKD managing several large engagements, both public and private. He then served as Controller for Ossip Optometry, where he transformed the accounting department along with leading the sell side diligence for a successful transaction. Chris then joined Anagin, Inc. as Director of Finance, an emerging biotech developing first-in-class novel targeted therapies for addressing pathologies associated with disrupted synaptic plasticity in the central nervous system.

Chris received his BS from Purdue University and holds an active CPA license.